These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 15003905)
1. Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies. De Fabritiis P; Dentamaro T; Picardi A; Cudillo L; Masi M; Amadori S Haematologica; 2004 Feb; 89(2):243-5. PubMed ID: 15003905 [No Abstract] [Full Text] [Related]
2. Use of recombinant factor VIIa in life-threatening bleeding following autologous peripheral blood stem cell transplantation complicated by platelet refractoriness. Culligan DJ; Salamat A; Tait J; Westland G; Watson HG Bone Marrow Transplant; 2003 Jun; 31(12):1183-4. PubMed ID: 12796803 [No Abstract] [Full Text] [Related]
3. [Efficacy of recombinant activated factor VII in diffuse alveolar haemorrhage]. Dabar G; Harmouche C; Jammal M Rev Mal Respir; 2011 Jan; 28(1):106-11. PubMed ID: 21277485 [TBL] [Abstract][Full Text] [Related]
4. [Diffuse alveolar hemorrhage after hematopoietic stem cell transplantation]. Mo XD; Huang XJ Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):216-9. PubMed ID: 23856148 [No Abstract] [Full Text] [Related]
6. Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation. Ma SY; Au WY; Lie AK; Ng IO; Leung AY; Tse EW; Liang RH; Lau GK; Kwong YL Bone Marrow Transplant; 2004 Jul; 34(1):57-61. PubMed ID: 15156162 [TBL] [Abstract][Full Text] [Related]
7. Recombinant factor VIIa in severe uremic bleeding. Révész T; Arets B; Bierings M; van den Bos C; Duval E Thromb Haemost; 1998 Aug; 80(2):353. PubMed ID: 9716175 [No Abstract] [Full Text] [Related]
8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
9. Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies. Chu T; Tang Y; Wang H; Qi J; Zhao Y; Pan T; Tang X; Qiu H; Fu C; Ruan C; Wu DP; Han Y Thromb Res; 2017 Dec; 160():14-18. PubMed ID: 29080548 [TBL] [Abstract][Full Text] [Related]
10. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687 [TBL] [Abstract][Full Text] [Related]
11. Comparative outcomes of reduced intensity and myeloablative allogeneic hematopoietic stem cell transplantation in patients under 50 with hematologic malignancies. Kim I; Yoon SS; Lee KH; Keam B; Kim TM; Kim JS; Kim HG; Oh MD; Han KS; Park MH; Park S; Kim BK Clin Transplant; 2006; 20(4):496-503. PubMed ID: 16842528 [TBL] [Abstract][Full Text] [Related]
12. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a. Hennewig U; Laws HJ; Eisert S; Göbel U Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424 [TBL] [Abstract][Full Text] [Related]
13. [Bleeding after cardiac surgery: the role of recombinant factor VIIa]. von Heymann C; Spies C; Grubitzsch H; Schönfeld H; Sander M; Volk T Hamostaseologie; 2006 Aug; 26(3 Suppl 1):S77-87. PubMed ID: 16953296 [TBL] [Abstract][Full Text] [Related]